Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MIF | P14174 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | APP | P05067 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 2/20 | 0.39 |
| ▸ | HTR3E | A5X5Y0 | 1/20 | 0.35 |
| ▸ | SLC22A2 | O15244 | 1/20 | 0.35 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.35 |
| ▸ | SLC22A3 | O75751 | 1/20 | 0.35 |
| ▸ | HTR3B | O95264 | 1/20 | 0.35 |
| ▸ | PLAU | P00749 | 1/20 | 0.35 |
| ▸ | HTR3A | P46098 | 1/20 | 0.35 |
| ▸ | HTR3D | Q70Z44 | 1/20 | 0.35 |
| ▸ | HTR3C | Q8WXA8 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 4/20 | 0.33 |
| ▸ | MEN1 | O00255 | 3/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.33 |
| ▸ | NOS3 | P29474 | 2/20 | 0.33 |
| ▸ | NOS1 | P29475 | 2/20 | 0.33 |
| ▸ | RAB9A | P51151 | 2/20 | 0.33 |
| ▸ | PKM | P14618 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1133446 | 1.00 | MIF (0.52) | MIFALDH1A1APPTSHRHTR3E | |
| SCHEMBL2003688 | 0.74 | — | — | |
| SCHEMBL4909471 | 0.73 | MIF (0.60) | MIFALDH1A1APPTSHRHTR3E | |
| SCHEMBL156948 | 0.73 | MIF (0.60) | MIFALDH1A1APPTSHRHTR3E | |
| SCHEMBL11489811 | 0.69 | MIF (0.43) | MIFALDH1A1TSHRMAPTMEN1 | |
| SCHEMBL132994 | 0.69 | — | — | |
| SCHEMBL5925 | 0.69 | — | — | |
| SCHEMBL22173631 | 0.69 | — | — | |
| SCHEMBL1332539 | 0.69 | — | — | |
| Phenylisothiocyanate SCHEMBL20984 | 0.69 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0470665-B1 | 1-Hydroxyindole fungicides | EASTMAN KODAK CO (US) | 1996-04-24 | — | — | EP | claimed |
| EP-0472231-B1 | 2-Substituted-1-hydroxyindoles | EASTMAN KODAK CO (US) | 1994-10-26 | — | — | EP | claimed |
| US-5183894-A | Agricultural fungicides | EASTMAN KODAK COMPANY (US) | 1993-02-02 | — | — | US | claimed |
| US-5118695-A | 1-HYDROXYINDOLE FUNGICIDES | EASTMAN KODAK COMPANY (US) | 1992-06-02 | — | — | US | claimed |
| EP-0472231-A1 | 2-Substituted-1-hydroxyindoles | EASTMAN KODAK COMPANY (US) | 1992-02-26 | — | — | EP | claimed |
| EP-0470665-A1 | 1-Hydroxyindole fungicides | EASTMAN KODAK COMPANY (US) | 1992-02-12 | — | — | EP | claimed |
| EP-2287141-B1 | METHOD FOR PRODUCING UNSATURATED ORGANIC COMPOUND | SUMITOMO CHEMICAL CO (JP) | 2015-10-21 | — | — | EP | disclosed |
| US-8237002-B2 | Method for producing unsaturated organic compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2012-08-07 | — | — | US | disclosed |
| US-20110046380-A1 | METHOD FOR PRODUCING UNSATURATED ORGANIC COMPOUND | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2011-02-24 | — | — | US | disclosed |
| EP-2287141-A1 | METHOD FOR PRODUCING UNSATURATED ORGANIC COMPOUND | Sumitomo Chemical Company, Limited (JP) | 2011-02-23 | — | — | EP | disclosed |
| EP-0470665-B1 | 1-Hydroxyindole fungicides | EASTMAN KODAK CO (US) | 1996-04-24 | — | — | EP | disclosed |
| EP-0472231-B1 | 2-Substituted-1-hydroxyindoles | EASTMAN KODAK CO (US) | 1994-10-26 | — | — | EP | disclosed |
| US-5183894-A | Agricultural fungicides | EASTMAN KODAK COMPANY (US) | 1993-02-02 | — | — | US | disclosed |
| US-5118695-A | 1-HYDROXYINDOLE FUNGICIDES | EASTMAN KODAK COMPANY (US) | 1992-06-02 | — | — | US | disclosed |
| EP-0472231-A1 | 2-Substituted-1-hydroxyindoles | EASTMAN KODAK COMPANY (US) | 1992-02-26 | — | — | EP | disclosed |
| EP-0470665-A1 | 1-Hydroxyindole fungicides | EASTMAN KODAK COMPANY (US) | 1992-02-12 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110046380-A1 | METHOD FOR PRODUCING UNSATURATED ORGANIC COMPOUND | NIT2, NOS1, CHRM1 | MIF 4294/4885ALDH1A1 948/4885APP 2210/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.